Icelandic pharmaceutical company Alvogen wins two prizes

Alvogen, an Icelandic pharmaceutical company based in 35 countries, has won two awards at an international pharmaceutical conference in Paris. Generics Bulletin, the leading newsletter for the generic industry, awarded Alvogen with Company of the Year in the USA and Business Development Project of the Year in Europe for the marketing of biotechnological drug Inflectra. 

Alvogen's largest market is the USA where it has rapidly grown in recent years. Other markets include South Asia and Eastern Europe.